Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine – Case Report

Publisher： Karger

E-ISSN： 2296-5262|33|1-2|53-56

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.1-2, 2010-01, pp. : 53-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Is Capecitabine Efficacious in Triple Negative Metastatic Breast Cancer?

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer Patient

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

The role of the androgen receptor in triple-negative breast cancer

By Shah Payal D   Gucalp Ayca   Traina Tiffany A  

Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. : 351-360

Future Medicine

Access to resources Recommend Favorite